Skip to content

A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems

A Prospective, Non-Controlled, Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00699270
Enrollment
0
Registered
2008-06-17
Start date
2007-08-31
Completion date
2008-12-31
Last updated
2017-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis, Humeral Fractures, Osteoarthritis, Rheumatoid Arthritis

Keywords

Total Shoulder Arthroplasty, Total Shoulder Replacement, Shoulder Arthritis

Brief summary

The purpose of this prospective clinical data collection is to document the performance and clinical outcomes of Biomet Humeral Stems

Interventions

None listed

Sponsors

Biomet Orthopedics, LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis * Rheumatoid Arthritis * Correction of functional deformity

Exclusion criteria

Absolute contraindications: \- Infection, Sepsis, and Osteomyelitis Relative contraindications: * Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions * Osteoporosis * Metabolic disorders which may impair bone function * Osteomalacia * Distant foci of infections which may spread to the implant site * Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram

Design outcomes

Primary

MeasureTime frame
UCLA End Result Score3 months, 6 months, 1 year, 3 years, 5 years
X-rays3 month, 1 year, 3 years, 5 years

Secondary

MeasureTime frame
Incidence of revisions and removalsAny time

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026